Saguaro Biosciences
PrivateLast Round
Grant
Nov 11, 2025
Total Funding Raised
$4.1M
Momentum Score
25 /100
Company Overview
Saguaro Biosciences is a biotechnology company that develops a live-cell image-based profiling platform designed to accelerate drug discovery and life sciences research.
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Saguaro Biosciences Comps
Public and private peers based on sector, stage, and business model.
Saguaro Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 11, 2025 | ||||
| Seed | Jun 4, 2024 | ||||
| Pre Seed | Feb 16, 2022 |
Key People
Founding team and executive leadership
Saguaro Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investissement Québec | Seed |
| Consortium Québécois sur la découverte du médicament | Grant |
| AQC Capital | Seed |
| Anges Quebec | Seed |
| Ville de Québec | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 26, 2026
Monthly visitors increased 551% MoM.
- Jan 6, 2026
Monthly visitors grew 87% MoM.
Saguaro Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Saguaro Biosciences's valuation, stock price, and market status.
